Deep Dive

R&D
r-and-d-innovation-1200x675

Deep Dive: R&D Innovation

In this issue of Deep Dive we look at innovation in pharma R&D, asking how can pharmaceutical companies change up the development model with new strategies and technologies to cut waste

Digital
Deep Dive Disruptive Technologies in pharma

Deep Dive: Disruptive Technologies

In the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they're changing medicine, research and development, and healthcare, and how the pharmaceutical i

Digital
digital health

European digital health innovation

Healthcare and the pharmaceutical industry are redefining their roles for the modern age as digital health tech radically alters the environment for all stakeholders.

Views & Analysis
Health-Prize-Technologies_banner_570x320

Non-adherence: pharma’s final financial frontier

No other industry would tolerate avoidable annual losses of $637 billion, but that’s exactly what pharma is doing by not investing in adherence. Now is the time to start recovering that revenue.

Views & Analysis
Kantar_banner_570x320

Uncovering patient-centred insights

There are good reasons why patient centricity has become such a well-used term within the pharmaceutical industry. But, says Kantar Health’s Linda VerPlanck, the research approaches underpinning it must be able to deliver transformational insights that can, in turn, improve real-world outcomes.